Bay Street News, August 28th, 2024

MINNEAPOLIS, Aug. 28, 2024 (GLOBE NEWSWIRE) — Perception Capital Corp. III (Nasdaq: PFTA) (the “Company”), a special purpose acquisition company, […]

ATLANTA, GA, Aug. 28, 2024 (GLOBE NEWSWIRE) — GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and […]

Summary: SoundThinking, Inc. today announced recently published independent research that demonstrates benefits of ShotSpotter in Winston-Salem, including lives saved, reduction […]

By regulatory requirement,THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES […]

NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory […]

CALGARY, Alberta, Aug. 28, 2024 (GLOBE NEWSWIRE) — Parex Resources Inc. (“Parex” or the “Company”) (TSX: PXT) provides an update […]

EMERYVILLE, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) — Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing […]

OTTAWA, Ontario, Aug. 28, 2024 (GLOBE NEWSWIRE) — Calian Group Ltd. (“Calian” or the “Company”) (TSX: CGY) is pleased to […]

HIGHLIGHTS Submitted application to designate Chvaletice Manganese Project as a Strategic Project under the EU’s Critical Raw Materials Act (CRMA) […]

OCOEE, FL, Aug. 28, 2024 (GLOBE NEWSWIRE) — iCoreConnect Inc. (NASDAQ: ICCT) (“iCore” or the “Company”), a leading provider of […]